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HPV vaccine found to be safe
Currently, 25% of girls aged between 13 and 17 years have received
at least one shot of Gardasil, the quadrivalent vaccine for human
papillomavirus (HPV). A recent study, in which the recipients of the
vaccine were followed up, showed that the HPV vaccine is no riskier
than other vaccines on the market today. There is, however, a small
chance of fainting after receiving the vaccine.
The study showed that about 23 million shots of the vaccine have
been given during the 2.5 years it has been in use. During this time
approximately 12 500 adverse events have been reported; however,
over 90% of thesewere not considered to be serious health complaints.
Thirty-two deaths were reported among womenwho received the
vaccine, but there was no definite evidence to suggest that the deaths
were directly caused by the vaccine and not merely a coincidence.
Fainting was reported in 8.2 cases per 100 000 vaccinations. Local
vaccine site reactions were also higher than for other vaccines at 7.5
per 100 000 vaccinations.
Although the vaccine has been shown to be generally safe, the
debate continues about whether countries are moving too fast to
make it part of their vaccination schedule for girls. Since the progress
from HPV infection to cervical cancer takes a long time, the benefit of
the vaccine in reducing the incidence of cervical cancer can only be
shown in about 20 to 40 years.⁎ Corresponding authors.
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Private–public partnerships improving maternal and newborn
health in India
More than 100 000 women die each year in India from pregnancy-
related causes. The level of maternal mortality and the pace at which
maternal mortality reduction efforts are progressing have led many to
doubt whether Millennium Development Goal 5 can be achieved.
However, there is good news from the western state of Gujarat,
which has a population of 50 million people. The state government
has linked up with private hospitals and doctors to provide free
obstetric care for poor women. The women receive free prenatal care,
free delivery services, and free postnatal care. Cesarean delivery is also
provided free of charge. Doctors also examine neonates at birth and
provide treatment for any problems that are detected. In this part-
nership, launched in 5 districts, the government pays for the services
rendered by private practitioners.
Reports show that institutional delivery rates have increased from
67% to 82% in the selected districts. Its success has led to the states of
West Bengal, Madhya Pradesh, and Uttar Pradesh starting similar
programs.
Reference
http://www.who.int/features/2009/private_public_benefits/en/
index.html.
Women's stories about HIV
The proportion of women living with HIV globally stabilized at
around 50% in the late nineties. The most recent estimates from 2007
put the figure at 50.2%. The World Health Organization estimates that
there are about 16 million women living with HIV throughout the
world, and more than 75% of these women live in Africa.
In Africa, 60% of adults living with HIV are women, while the
Western Pacific has the lowest prevalence of 28%. Compared with
men, women are physically more susceptible to HIV infection and are
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The features section of the WHOwebsite contains women's stories
documenting their experiences with HIV. The stories reveal how these
women were exposed to violence and gender inequality, as well as
their experiences living with HIV.
Balabwa, fromSouthAfrica,was infectedwithHIV after she had been
raped. At diagnosis she was also found to have contracted tuberculosis
and was declared to be beyond help. However, she received support
from a nongovernmental organization to treat the tuberculosis and
received antiretroviral drugs. She now serves as an advocate against
gender-based violence and works with others living with HIV.
WHO is working to scale up the provision of treatment to people
living with HIV. In 2007, only 3 million people had access to treatment
out of the 9.7 million in low-income nations who needed treatment.
Reference
http://www.who.int/features/2004/aids/en/index.html.
Expanded antiretroviral treatment shows benefits in Namibia
Namibia has one of the highest rates of HIV infection in the world,
with 15% of the adult population diagnosed as HIV positive. However,
scaling up of provision of antiretroviral treatment for those infected
has begun to show benefits.
The Katutura State hospital started providing counseling and
testing services and antiretroviral treatment in 2003. There are many
free HIV testing sites established in the Katutura vicinity. It is at these
testing sites that people can find out their HIV status. After learning
their HIV status, those testing positive are directed to the state hos-pital where they receive antiretroviral therapy as well as treatment for
opportunistic infections.
The service at Katutura State hospital has subsequently grown to
the point where 5000 HIV positive adults and 1100 children receive
treatment regularly. In addition, about 80–120 newly tested people
are enrolled for treatment each month. The hospital also provides
counseling, testing, and treatment services for pregnant HIV-positive
women.
Reference
http://www.who.int/features/2009/hiv_namibia/en/index.html.
Women's health: Useful sources of information
The Database of Abstracts of Reviews of Effects (DARE) is a
searchable database for abstracts of reviews and meta-analyses that
have been performed on any reproductive health topic. This database
is a good starting point for discovering reviews published on a topic of
interest. It is also useful for getting a quick summary of the current
evidence-based recommendations. DARE can be accessed at: http://
www.crd.york.ac.uk/crdweb/Home.aspx. A DARE tab then takes users
to the search page.
The Geneva Foundation for Medical Education and Research
(GFMER) provides a means of access to all published guidelines,
reviews, position statements, recommendations, and standards in
obstetrics, gynecology and reproductive medicine. Users have access
to full text articles and the website is available in English, French,
Spanish, Italian, and German. The web address is: http://www.gfmer.
ch/Guidelines/Obstetrics_gynecology_guidelines.php.
